Новые аспекты диагностики и ведения пациентов с лекарственно-индуцированной головной болью
https://doi.org/10.21518/2079-701X-2013-12-14-19
Аннотация
Об авторах
В. А. ГоловачеваРоссия
В. В. Осипова
Россия
Список литературы
1. Азимова Ю.Э., Табеева Г.Р. Головная боль, связанная с избыточным приемом лекарственных средств (абузусная головная боль). Фарматека, 2012;6:10-14.
2. Наумова Г.И., Осипова В.В. Лекарственно-индуцированная головная боль: тактика ведения пациента. Неврология и нейрохирургия в Беларуси, 2011;3(11):22-34.
3. Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akerhus study of chronic headache. Cephalalgia, 2008;28:705-713.
4. Altieri M, Di Giambattista R, Di Clemente L, et al. Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: a pilot study. Cephalalgia, 2009;29:293-299.
5. Antonaci F, Dumitrache C, De Cillis I, et al. A review of current European treatment guidelines for migraine. J. Headache Pain, 2010;11:13-19.
6. Baandrup L, Jensen R. Chronic post-traumatic headache – a clinical analysis in relation to the International Headache Classification 2nd Edition. Cephalalgia, 2005;25:132-138.
7. Bahra A, Walsh M, Menon S, et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache, 2003;43:179-190.
8. Bauer B, Evers S, Lindorfer HW, et al. Headache caused by sphenoid mucocele but presenting as an ergotamine-induced headache. Headache, 1997;376:460-462.
9. Bendtsen L. Drug and nondrug treatment in tension type headache. Ther. Adv. Neurol. Disord. 2009;2(3):155-161.
10. Bigal ME, Serrano D, Buse D. et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache, 2008;48:1157-1168.
11. Boe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology, 2007;69:26-31.
12. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia, 2009;29:855-863.
13. Cady RK, Schreiber CP. Sinus problems as cause of headache refractoriness and migraine chronification. Curr. Pain Headache Rep., 2009;13:319-325.
14. Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology, 2004;62:1338-1342.
15. Corbelli I., Caproni S., Eusebi P. et al. Drug-dependence behaviour and outcome of medication-overuse headache after treatment. J Headache Pain, 2012;13:653-660.
16. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia, 2009;29:1021-1027.
17. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol., 2004;3:475-483.
18. Evers S, Bauer B, Suhr S. Ergotamine-induced headache associated with cluster headache. Neurology, 1996;46:291.
19. Evers S, Jensen R. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur. J. Neurol., 2011;18:1115-1121.
20. Evers S, Marziniak M. Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol., 2010;9:391-401.
21. Ghiotto N, Sances G, Galli F, et al. Medication overuse headache and applicability of the ICHD-II diagnosic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia, 2009;29:233-243.
22. Grazzi L, Andrasik F, Usai S, et al. In patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment results at one-year follow-up. Neurol. Sci, 2008;29(1):161-163.
23. Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia, 2009;29:221-232.
24. Неadache Classification Committee. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 1988;8(7):1-96.
25. Headache Classification Subcommittee of the International Headache Society. The international Classification of Headache Disorders, 3nd Edition (ICHD-3 beta). Cephalalgia, 2013;33(9):629-808.
26. Headache Classification Subcommittee. The international classification of headache disorders. Cephalalgia, 2004;24(1):1-160.
27. Holland S, Silberstein SD, Freitag F, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology, 2012;78(17):1346-1353.
28. Jensen R, Zeeberg P, Dehlendorff C, et al. Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalgia, 2010;30:1214-1224.
29. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia, 2011;31:1015-1022.
30. Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drug. Neurology, 2001;57:1694-1698.
31. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia, 2005;25:12-15.
32. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia, 2000;20:107-113.
33. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache, 1988;28:61-62.
34. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur. J. Neurol., 2012;19:703-711.
35. Obermann M, Katsarava Z. Management of medication overuse headache. Expert Rev. Neurother., 2007;7:1145-1155.
36. Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology, 2006;67:109-113.
37. Paemelaire K, Crevitis L, Goadsby PH, et al. Practice management of medication overuse headache. Acta. Neurol. Belg., 2006;106:43-51.
38. Pageler L, Katsarava Z, Diener HC, et al. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia, 2008;28:152-156.
39. Pageler L, Savidou I, Limmroth V. Medication-overuse headache. Curr. Pain Headache Rep., 2005;5:529-536.
40. Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr. Pain Headache Rep., 2001;5:529-536.
41. Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia, 2008;28:1196-1200.
42. Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur. J. Neurol., 2011;18:396-401.
43. Rossi P, Faroni JV, Tassorelli C, et al. Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J. Headache Pain, 2013;14:10.
44. Rossi P, Jensen R, Nappi G, et al. The COMOES-TAS Consortium. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J. Headache Pain, 2009;10:407-417.
45. Suhr B, Evers S, Bauer B, et al. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia, 1999;19:44-49.
46. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia, 2010;30:329-336.
47. Silberstein SD, Olesen J, Bousser MG, et al.; International Headache Society The International Classificattion of Headache Disorders, 2nd Edition (ICHD-II) – reversion of criteria for 8.2 Medication-overuse headache. Cephalalgia, 2005;25:460-465.
48. Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia, 2009;30:207-213.
49. Willer L, Jensen R, Juhler M. Medication overuse as a cause of chronic headache in shunted hydrocephalus patients. JNNP, 2010;81:1261-1264.
50. Wolfe S, Van Stavern G. Characteristics of patients presenting with ocular pain. Can. J. Ophthalmol., 2008;43:432-434.
51. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia, 2006;26:1192-1198.
52. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology, 2006;66:1894-1898.
53. Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck and low-back pain. Neurology, 2004;62:1540-1544.
Рецензия
Для цитирования:
Головачева В.А., Осипова В.В. Новые аспекты диагностики и ведения пациентов с лекарственно-индуцированной головной болью. Медицинский Совет. 2013;(12):14-19. https://doi.org/10.21518/2079-701X-2013-12-14-19
For citation:
Golovacheva V.А., Osipova V.V. New aspects of diagnosis and management of patients with drug-induced headache. Meditsinskiy sovet = Medical Council. 2013;(12):14-19. (In Russ.) https://doi.org/10.21518/2079-701X-2013-12-14-19